Lurje, I., Uluk, D., Tacke, F., & Lurje, G. (2025). Letter: Comparing the efficacy of adjuvant PD-1 inhibitor after curative resection for metabolic dysfunction-associated steatotic liver disease related HCC versus other aetiologies: Authors' reply. Alimentary pharmacology & therapeutics, 61(11), . https://doi.org/10.1111/apt.70126
Chicago-Zitierstil (17. Ausg.)Lurje, Isabella, Deniz Uluk, Frank Tacke, und Georg Lurje. "Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-associated Steatotic Liver Disease Related HCC Versus Other Aetiologies: Authors' Reply." Alimentary Pharmacology & Therapeutics 61, no. 11 (2025). https://doi.org/10.1111/apt.70126.
MLA-Zitierstil (9. Ausg.)Lurje, Isabella, et al. "Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-associated Steatotic Liver Disease Related HCC Versus Other Aetiologies: Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 61, no. 11, 2025, https://doi.org/10.1111/apt.70126.